Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia
about
A systematic examination of brain volumetric abnormalities in recent-onset schizophrenia using voxel-based, surface-based and region-of-interest-based morphometric analysesMagnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future researchStructural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia.Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility?Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation.Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis.Striatal dopamine release in schizophrenia comorbid with substance dependence.Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review.Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex.Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studiesStructural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysisGlucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits.Heritability of subcortical and limbic brain volume and shape in multiplex-multigenerational families with schizophreniaHippocampal volume development in healthy siblings of childhood-onset schizophrenia patients.Decreased bilateral thalamic gray matter volume in first-episode schizophrenia with prominent hallucinatory symptoms: A volumetric MRI study.Pathophysiological distortions in time perception and timed performance.Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness.Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in PsychosisFrontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockadeBasal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review.The human brain representation of odor identification.Extrastriatal dopamine D2/3 receptors and cortical grey matter volumes in antipsychotic-naïve schizophrenia patients before and after initial antipsychotic treatment.Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia.Melatonin stimulates dendrite formation and complexity in the hilar zone of the rat hippocampus: participation of the Ca++/Calmodulin complex.Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels.Discrete pre-processing step effects in registration-based pipelines, a preliminary volumetric study on T1-weighted images.Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient.Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients.Brain differences in first-episode schizophrenia treated with quetiapine: a deformation-based morphometric study.First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.Extensive brain structural network abnormality in first-episode treatment-naive patients with schizophrenia: morphometrical and covariation study.Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.Impaired temporoparietal deactivation with working memory load in antipsychotic-naïve patients with first-episode schizophreniaSynaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.The impact of schizophrenia and intelligence on the relationship between age and brain volume
P2860
Q24288871-07BC91BA-CA75-41C9-8D4D-10D534E3D4F8Q28082090-E63AA0FC-6B28-473D-88B7-AF63F6860400Q29364530-0A2A3CA8-AE53-46FD-A4F7-B61853EB3E93Q33560201-F8B8AB14-3254-4B64-A87B-34F6905727CEQ33678755-C0F8CE3A-5FDB-49DC-B4D6-EEBBB36A0F6AQ33885557-EB4F2DB4-2658-49CB-96F6-D71140F633A7Q34028727-B94B882F-FE8F-4367-B687-240A000DDEF5Q34034400-25EB5483-C99C-497E-B21D-E48F79BF37A2Q34264958-851EB19C-C16B-43DD-AB30-60302B5D54D4Q34282907-2857072B-E12F-486B-B916-8504A490A8B9Q34369803-D31B2415-7353-48DA-9948-B68B13C6B267Q34379379-B7553264-5C0E-4489-B02E-ADA569B74EAEQ34585557-6DFD2C98-46D5-4472-B518-97A43E9CDBF8Q35786372-17B243DB-1805-417F-968E-20BAC14295C5Q36099986-392C7529-0EB9-4C3C-BB41-60EBF19412F2Q36378946-0390687E-ADDB-4849-8127-63EBD8354869Q36390750-D5689D65-F6A4-4A16-99F0-79930F53D744Q36579982-E1E1EFAB-6B25-44C9-ABE1-952904C53B29Q36609798-C56C63A9-C425-4300-AE26-FFA62AE1AE87Q37627386-30284E1E-CFCA-410B-B5B4-BDE72439B24BQ37969149-F265A0EB-7597-4638-811C-2B48A73ABFA0Q38472574-7AE56D56-1747-47CE-AB76-A1C38FB22604Q39248594-7442828D-D77B-4394-9305-EC2B28CCF8F2Q39340879-E7CE8888-A962-4CE2-822E-EA88BC7D5C94Q41556811-20B944B0-208F-475D-B70B-F48944690978Q41724967-0E74F202-553D-49B5-A5EE-ED6015518A13Q42099006-CC382A2C-4A00-4B5B-B1F5-3580488AC6D7Q42375734-417E8CCE-DA32-48CD-987E-E2B60D29F2F6Q44278018-1B019C98-1C9C-4AC7-93E8-3DC3125D092DQ47173322-5464005C-EBAA-40A6-A58D-37DA8B950FC5Q48093284-715855C8-E710-4D36-9A83-1B44AFB039A3Q48288493-45C094C5-1755-44CF-9A4C-1AB94645D270Q48626810-068C40FE-68E7-4DB2-928B-C07EDA525D07Q50556051-CDCDA8B4-958D-40A4-B9C2-9B06C963C63DQ50664683-4AC8AC93-0AC4-4B28-9BB8-3090C2EFB866Q50925476-2300DC18-ABE4-40B4-9B44-D5D79E5AA1A6Q51017971-D3A8CB05-800E-456A-BB8D-AADA579D870EQ51743706-8F614B9D-BA42-4521-AE97-A9E6E34CBC8AQ57297739-C0A1AA8D-F752-449F-8319-C65840FAC049
P2860
Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@ast
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@en
type
label
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@ast
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@en
prefLabel
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@ast
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@en
P2093
P2860
P50
P356
P1476
Hippocampal and caudate volume ...... ve first-episode schizophrenia
@en
P2093
Annika R Langkilde
Bjørn H Ebdrup
Bodil Aggernaes
Hans Rasmussen
P2860
P304
P356
10.1503/JPN.090049
P577
2010-03-01T00:00:00Z